Publications
Antiproliferative Mechanism of Action of the Novel Taxane Cabazitaxel as Compared with the Parent Compound Docetaxel in MCF7 Breast Cancer Cells. American Association for Cancer Research. 13:2092–2103.
.
2014. $\beta$III-tubulin enhances efficacy of cabazitaxel as compared with docetaxel. Cancer Chemotherapy and Pharmacology. :1–14.
.
2017.